Vanguard Group’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Vanguard Group’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,965,074	Closed	-$213M	–	4183
2014 Q4	$213M	Buy	5,965,074 +69,697	+1%	+$2.08M	0.02%	935
2014 Q3	$153M	Buy	5,895,377 +20,662	+0.4%	+$593K	0.01%	1096
2014 Q2	$194M	Buy	5,874,715 +181,401	+3%	+$5.24M	0.02%	975
2014 Q1	$170M	Buy	5,693,314 +95,168	+2%	+$3.28M	0.01%	1020
2013 Q4	$170M	Buy	5,598,146 +136,389	+2%	+$3.76M	0.01%	991
2013 Q3	$174M	Buy	5,461,757 +97,331	+2%	+$2.23M	0.02%	917
2013 Q2	$81M	Buy	+5,364,426	New	+$74.3M	0.01%	1306

Other funds holding NPSP

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Vanguard Group's NPSP Position: Q1 2015 in Review

Vanguard Group sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 5,965,074 shares — an estimated $213M sold.

Vanguard Group first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $213M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

Vanguard Group reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Vanguard Group sold 5,965,074 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $213M.
Vanguard Group first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Vanguard Group's NPS PHARMACEUTICALS INC position peaked at $213M in Q4 2014.
1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.